Ignite Creation Date:
2024-05-06 @ 12:32 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03786692
Status:
RECRUITING
Last Update Posted:
2024-02-12
First Post:
2018-12-21
Brief Title:
Phase II Randomized Trial of CarboplatinPemetrexedBevacizumab- Atezolizumab in Stage IV NSCLC
Sponsor:
Organization:
Fox Chase Cancer Center